Janney Montgomery Scott LLC Decreases Stock Position in Exponent, Inc. $EXPO

Janney Montgomery Scott LLC reduced its position in Exponent, Inc. (NASDAQ:EXPO) by 2.3% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 47,664 shares of the business services provider’s stock after selling 1,102 shares during the quarter. Janney Montgomery Scott LLC owned approximately 0.09% of Exponent worth $3,561,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently made changes to their positions in EXPO. Brooklyn Investment Group boosted its holdings in shares of Exponent by 10,200.0% in the first quarter. Brooklyn Investment Group now owns 309 shares of the business services provider’s stock worth $25,000 after acquiring an additional 306 shares during the period. UMB Bank n.a. boosted its holdings in shares of Exponent by 859.1% in the first quarter. UMB Bank n.a. now owns 633 shares of the business services provider’s stock worth $51,000 after acquiring an additional 567 shares during the period. Bessemer Group Inc. boosted its holdings in shares of Exponent by 103.3% in the first quarter. Bessemer Group Inc. now owns 681 shares of the business services provider’s stock worth $55,000 after acquiring an additional 346 shares during the period. SVB Wealth LLC bought a new position in shares of Exponent in the first quarter worth $80,000. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in shares of Exponent by 8,092.9% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,147 shares of the business services provider’s stock worth $93,000 after acquiring an additional 1,133 shares during the period. 92.37% of the stock is owned by institutional investors.

Exponent Stock Performance

NASDAQ:EXPO opened at $66.60 on Thursday. The firm has a market capitalization of $3.36 billion, a price-to-earnings ratio of 33.30 and a beta of 0.91. Exponent, Inc. has a 52-week low of $63.81 and a 52-week high of $115.75. The stock has a fifty day moving average of $70.09 and a 200 day moving average of $74.50.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Thursday, July 31st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.04. The company had revenue of $132.87 million during the quarter, compared to analyst estimates of $130.82 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%.The firm’s quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter last year, the company earned $0.57 earnings per share. Equities analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Exponent Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Friday, September 5th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, September 5th. This represents a $1.20 annualized dividend and a yield of 1.8%. Exponent’s dividend payout ratio (DPR) is currently 60.00%.

Insider Activity

In other Exponent news, CEO Catherine Corrigan sold 4,905 shares of Exponent stock in a transaction dated Monday, September 15th. The stock was sold at an average price of $69.91, for a total transaction of $342,908.55. Following the completion of the sale, the chief executive officer owned 82,753 shares of the company’s stock, valued at $5,785,262.23. The trade was a 5.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Joseph Sala sold 1,595 shares of Exponent stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total value of $112,670.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 11,396 shares of company stock valued at $803,636. Corporate insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Exponent in a report on Wednesday. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Exponent has an average rating of “Hold”.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.